Thomas Jefferson University, United States.
Mol Immunol. 2013 Sep;55(2):169-71. doi: 10.1016/j.molimm.2012.10.020. Epub 2012 Nov 30.
By convention, peptides presented at the cell surface by MHC class II molecules (MHCII) are derived from internalized ("exogenous") antigen that is denatured and fragmented in the endocytic compartment and loaded onto MHC in the late endosome with the assistance of the H2-DM chaperone. Over the past two decades several alternatives to this pathway have been described but the extent to which they contribute to natural CD4(+) T cell (T(CD4+))) responses has not been assessed, mainly because studies have focused primarily on individual epitopes. My laboratory has begun to address this issue in virus infection models and a picture is emerging in which classical presentation plays a relatively minor role, with a number of alternative presentation pathways collectively accounting for the majority of peptide presentation. The potential ramifications for this fundamentally altered view of MHCII peptide supply are discussed.
根据惯例,由 MHC Ⅱ类分子(MHCⅡ)在细胞表面呈递的肽来源于内吞的(“外源性”)抗原,该抗原在内体中变性和碎片化,并在晚期内体中在 H2-DM 伴侣的协助下加载到 MHC 上。在过去的二十年中,已经描述了几种替代该途径的方法,但它们对天然 CD4(+)T 细胞(T(CD4+))反应的贡献程度尚未评估,主要是因为研究主要集中在单个表位上。我们实验室已经开始在病毒感染模型中解决这个问题,一个正在出现的画面是,经典呈递的作用相对较小,许多替代呈递途径共同构成了大多数肽呈递的基础。讨论了这种对 MHCⅡ类肽供应的根本改变的看法的潜在影响。